Govt To Reduce Dependency On Import For Pharma, Medical Devices

New Delhi : Union Minister for Chemicals and Fertilizers and Health and Family Welfare, Dr Mansukh Mandaviya today said that the government had decided to reduce the dependency on import for pharma and medical devices to meet the critical requirements of the country.

He said that the domestic manufacturing needed to scale up as the country wanted to dominate the world. Its aim is not to be dependent on anyone.

Addressing a press conference the Minister said that currently India had highest manufacturing capacity for generic medicines. In order to increase the production of patented drugs manufacturing in India, both innovation and research is required. To bring more innovation and research, the government is taking various steps and soon the government will announce a policy also in this regard.

This conference will decide the roadmap of Indian Pharma and Indian Medical devices sector for the next 25 years to take India beyond ‘Pharmacy of the World, he said.

Speaking on the occasion, Minister of State, BhagwanthKhuba said that with the growth in pharmaceutical sector, India was aspiring to become a pharmaceutical hub. He further stated that to boost the Indian medical devices sector the country needed to bring new technologies, innovation along with focus on Research and Development activities.

Secretary, Department of Pharmaceuticals, S. Aparna said that Indian Pharmaceutical and Medical Device Sector required collaboration between industries, academia, researchers, regulators and policymakers that would help these two sectors. The government has formulated several mechanisms including empowered group of secretaries, project development cell, PLI schemes, and a conducive policy environment to strengthen the pharma and medical device ecosystems.

  • Related Posts

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India